NYSE:CRLLife Sciences
Charles River (CRL) Deepens Lilly AI Partnership: What Does TuneLab Access Mean for Its Moat?
On 18 June 2026, Eli Lilly’s Lilly TuneLab announced a collaboration under which Charles River Laboratories will provide standardized nonclinical testing services to AI/ML-driven drug discovery companies using the platform.
This arrangement links Charles River directly into an AI-enabled ecosystem built on decades of Lilly research data, potentially deepening its role in data-rich, next-generation preclinical research workflows.
We’ll now examine how Charles River’s role in Lilly’s...